Nykode Therapeutics Stock
Stocks
VACC
NO0010714785
Biotechnology & Medical Research
OTC Markets Traded|
Real-time
Oslo Bors
15:44:37 27/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 4.850 NOK | +5.43% |
|
+18.29% | +101.08% |
| 08-20 | Nykode Therapeutics Wins New US Patent for Neoantigen-based Cancer Vaccine | MT |
| 08-06 | Nykode Therapeutics Asa Announces Appointment of Jakob Helding Rasmussen as Chief Technology Officer | CI |
| Market Cap | 1.5B 161M 138M 129M 118M 223M 15.31B 224M 1.53B 593M 7.72B 603M 590M 25.59B | P/E 2026 * |
-7.06x | P/E 2027 * | -12.4x |
|---|---|---|---|---|---|
| Enterprise Value | 1.02B 109M 93.38M 87.64M 80.05M 151M 10.38B 152M 1.04B 402M 5.23B 408M 400M 17.34B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
56.4% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Nykode Therapeutics
| 1 day | +5.43% | ||
| 1 week | +18.29% | ||
| Current month | +43.49% | ||
| 1 month | +50.86% | ||
| 3 months | +54.21% | ||
| 6 months | +67.59% | ||
| Current year | +101.08% |
| 1 week | 4.1 |  | 5.2 |
| 1 month | 3.08 | | 5.2 |
| Current year | 2.21 | | 5.2 |
| 1 year | 1.44 | | 5.2 |
| 3 years | 1.44 | | 30.18 |
| 5 years | 1.44 | | 85.3 |
| 10 years | 1.44 | | 93 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Engsig
CEO | Chief Executive Officer | 54 | 01/01/2019 |
| President | 49 | 01/01/2017 | |
Harald Gurvin
DFI | Director of Finance/CFO | 51 | 03/05/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 54 | - | |
Trygve Lauvdal
BRD | Director/Board Member | 57 | - |
Susanne Stuffers
CHM | Chairman | 45 | 23/04/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 3/27/25 A | Buy | Company | 3,000,000 | 0.9187% | ||
| 12/20/24 A | Buy | Director | 100,000 | 0.0306% | ||
| 12/20/24 A | Sell | Director | 100,000 | 0.0306% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.43% | +18.29% | +210.90% | -82.06% | 161M | |
| +3.31% | -3.70% | +61.03% | +103.64% | 70.42B | |
| +1.05% | +2.46% | +49.28% | +93.14% | 65.4B | |
| -1.31% | -0.50% | +7.41% | -4.29% | 28.28B | |
| -0.49% | +1.73% | +59.01% | +11.60% | 26.57B | |
| +0.40% | -4.80% | -5.89% | +469.55% | 27.16B | |
| +0.95% | +1.96% | +37.56% | -17.00% | 20.09B | |
| +1.02% | +6.43% | +269.42% | +420.34% | 20.61B | |
| +0.77% | -1.59% | +13.19% | +543.56% | 15.87B | |
| -1.09% | +3.14% | +46.32% | +155.12% | 13.9B | |
| Average | +1.01% | +0.37% | +74.82% | +169.36% | 28.85B | |
| Weighted average by Cap. | +1.04% | +0.72% | +56.62% | +157.47% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -209M -22.39M -19.22M -18.04M -16.47M -31.09M -2.14B -31.24M -213M -82.72M -1.08B -84.06M -82.23M -3.57B | -129M -13.83M -11.87M -11.14M -10.17M -19.2M -1.32B -19.29M -132M -51.08M -665M -51.91M -50.78M -2.2B |
| Net Debt | -484M -51.74M -44.41M -41.69M -38.07M -71.85M -4.94B -72.2M -493M -191M -2.49B -194M -190M -8.25B | -628M -67.16M -57.65M -54.11M -49.42M -93.26M -6.41B -93.71M -640M -248M -3.23B -252M -247M -10.7B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 27/08/26 | NOK 4.850 | +5.43% | 3,800,647 |
| 26/08/26 | NOK 4.600 | -0.86% | 11,640,937 |
| 25/08/26 | NOK 4.640 | +1.75% | 1,905,918 |
| 24/08/26 | NOK 4.560 | +1.11% | 3,036,452 |
| 21/08/26 | NOK 4.510 | +10.00% | 6,809,048 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VACC Stock
Select your edition
All financial news and data tailored to specific country editions
